Sr. Director and Scientific Lead; Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM) @ (May 2009 - May 2012)
Senior Director, Clinical PK and PD and DMPK Functional Area Operations Lead @ (January 2008 - April 2009)
Director, Clinical PK and PD @ (June 2006 - December 2007)
Associate Director, Pharmacokinetics and Biopharmaceutics @ (October 2003 - May 2006)
Research Fellow @ (February 2001 - September 2003)
Senior Research Pharmacokineticist @ (November 1996 - January 2001)
Nancy Agrawal Education
University of Michigan
PhD (Chemical Engineering)
1994-1996
University of Michigan
MS (Chemical Engineering)
1990-1994
Kansas State University
BS (Chemical Engineering)
1986-1990
Nancy Agrawal Skills
DMPK
Pharmacokinetics
Clinical Development
Pharmacodynamics
Drug Metabolism
Regulatory Submissions
Small Molecules
PK/PD
Drug Development
Drug Discovery
Biomarkers
IND
Biomarker Discovery
Clinical Pharmacology
ADME
Pharmaceutical Industry
Biotechnology
Biopharmaceutics
Forms
Data Analysis
Business Development
Healthcare
Operations
Marketing
Healthcare Management
Nancy Agrawal Summary
Nancy Agrawal, based in United States, is currently a Executive Vice President, Preclinical Development at Atea Pharmaceuticals, Inc. Nancy Agrawal brings experience from previous roles at Merck. Nancy Agrawal holds a 1994 - 1996 PhD in Chemical Engineering @ University of Michigan. With a robust skill set that includes DMPK, Pharmacokinetics, Clinical Development, Pharmacodynamics, Drug Metabolism and more. Nancy Agrawal has 2 emails on RocketReach.
Looking for a different Nancy Agrawal?
Find contact details for 700 million professionals.